Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
2024年4月1日 - 8:00PM
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced
that the company will host a fireside chat at the 23rd Annual
Needham Virtual Healthcare Conference on Monday, April 8, 2024, at
12:45 p.m. ET.
The live conference webcast will be posted on the “Events and
Presentations” page of the “Investors and Media” section of the
company’s website. A replay of the webcast will be available for
approximately 90 days following the event.
About ApellisApellis Pharmaceuticals, Inc. is a
global biopharmaceutical company that combines courageous science
and compassion to develop life-changing therapies for some of the
most challenging diseases patients face. We ushered in the first
new class of complement medicine in 15 years and now have two
approved medicines targeting C3. These include the first and only
therapy for geographic atrophy, a leading cause of blindness around
the world. We believe we have only begun to unlock the potential of
targeting C3 across serious retinal, rare, and neurological
diseases. For more information, please visit
http://apellis.com or follow us
on Twitter and LinkedIn.
Investor Contact: Meredith
Kaya meredith.kaya@apellis.com617.599.8178
Apellis Pharmaceuticals (NASDAQ:APLS)
過去 株価チャート
から 4 2024 まで 5 2024
Apellis Pharmaceuticals (NASDAQ:APLS)
過去 株価チャート
から 5 2023 まで 5 2024